<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR46">
 <label>46</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Byrn</surname>
    <given-names>RA</given-names>
   </name>
  </person-group>
  <article-title>Preclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunit</article-title>
  <source>Antimicrob. Agents Chemother.</source>
  <year>2015</year>
  <volume>59</volume>
  <fpage>1569</fpage>
  <lpage>1582</lpage>
  <?supplied-pmid 25547360?>
  <pub-id pub-id-type="pmid">25547360</pub-id>
 </element-citation>
</ref>
